Trial Profile
A single-center, placebo-controlled study of the effects of ascending single oral doses of aliskiren compared with captopril on renal hemodynamics in healthy volunteers on a low and high sodium diet 'renin inhibition and the kidney'
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Captopril
- Indications Acute heart failure; Diabetic macular oedema; Diabetic nephropathies; Heart failure; Hypertension; Myocardial infarction
- Focus Pharmacodynamics
- Sponsors Novartis
- 16 Jul 2008 Actual end date is added (August 2007) as reported by ClinicalTrials.gov.
- 16 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 24 Jan 2008 The expected completion date for this trial is now 1 Jan 2008.